Local, Targeted Therapy With Alpha Emitter [225Ac]Ac-DOTA-SP (TAT) In Newly Diagnosed Glioma (WHO G3-G4)

Abroad (travel likely)Recruiting

Conditions

Glioblastoma · High-Grade Glioma (WHO III-IV) · Glioblastoma (GBM)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Department of Neurosurgery, Medical University of Warsaw, Banacha 1a, Warsaw, Poland, Poland
Contact: Study coordinator (Przemysław Kunert, Professor MD PhD) · przemyslaw.kunert@wum.edu.pl · +48 22 599 2575
Contact: Study coordinator (Kacper Koczyk, MD) · kacper.koczyk@wum.edu.pl · +48 22 599 2575
Department of Neurosurgery, National Instiute of Oncology, W.K. Roentgena 5, Warsaw, Poland, Poland
Contact: Study coordinator (Henryk Koziara, MD PhD) · neurochirurgia@nio.gov.pl · +48 22 546 29 59

Study leads

Przemysław Kunert, Professor MD PhD
Principal Investigator
Medical University of Warsaw
Joanna Kunikowska, Professor MD PhD
Study Director
Medical University of Warsaw

View source on ClinicalTrials.gov Contact study team (email)